Skip to main content

Table 2 Alternative Anti-Malarial Prescribing in the Presence and Absence of ACT Stock

From: Taking stock: provider prescribing practices in the presence and absence of ACT stock

Country, Year % (No.) of patients diagnosed with uncomplicated malaria/fever and prescribed Alternative (non-ACT) Anti-Malarial
  At all facilities,
% (n)
At facilities with ACT stock, % (n) At facilities with no ACT stock, % (n) % differencea
(95% Confidence Intervalc; p-value)
Kenya, 2006 [19] 50.5% (475/940) 47.8%
(414/866)
82.4%
(61/74)
-34.6%
(-44.6%, -24.6%; p < 0.001)
Kenya, 2010 [14] 8.6% (183/2125) 8%
(162/2025)
21%
(21/100)
-13%
(-21.6%, -4.4%; p < 0.001)
Uganda, 2007 [18] < 5 yrs < 5 yrs < 5 yrs < 5 yrs
  19.5%
(90/461)
16.4%
(70/428)
60.6%
(20/33)
-44.2%
(-62.9%, -25.6%; p < 0.001)
  ≥ 5 yrs ≥ 5 yrs ≥ 5 yrs ≥ 5 yrs
  26.7% (197/739) 22.5%
(145/644)
54.7%
(52/95)
-32.2%
(-43.3%, -21.1%; p < 0.001)
Zambia, 2004 [16] ≥ 10 kg ≥ 10 kg ≥ 10 kg ≥ 10 kg
  72.3% (285/394) 56.8%
(109/192)
87.1% (176/202) -30.3%
(-39.3%, -21.5%, p < 0.001)
Zambia, 2006 [17] 5-9 kg 5-9 kg 5-9 kg 5-9 kg
  43.5% (240/552) 24.2%
(85/351)
77.1%
(155/201)
-52.9%
(-60.6%, -45.2%; p < 0.001)
  ≥ 10 kg ≥ 10 kg ≥ 10 kg ≥ 10 kg
  34.6% (189/547) 17.4% (65/374) 71.7%
(124/173)
-54.3%
(-62.5%, -46.1%; p < 0.001)
Zambia, 2006 [15]b 36.6% (533/1457) 23.1%
(240/1040)
70.3% (293/417) -47.2%
(-52.4%, -41.9%; p < 0.001)
  1. a Difference is the proportion of patients who received alternative anti-malarials at facilities with ACT stock minus the proportion of patients who received alternative anti-malarials at facilities with no ACT stock
  2. b Analysis restricted to facilities where diagnostics were available, test negative results excluded from analysis
  3. c Confidence interval not adjusted for clustering at facility level